Tenet Florida Physician Services (TFPS) is pleased to announce Brijeshwar Maini, M.D., FACC, a structural heart cardiologist and the Regional Medical Director of Transcatheter Therapies for Tenet Florida, has joined the TFPS multispecialty physician group network. Dr. Maini has opened an office in Delray Beach and is on staff at Delray Medical Center, Palm Beach Gardens and Florida Medical Center, a campus of North Shore located in Fort Lauderdale.
Prior to joining TFPS, Dr. Maini worked as director of structural heart and advanced cardiovascular interventions at Pinnacle Health Cardiovascular Institute, medical director of the Pinnacle Health Valve Clinic as well as the director of research at Pinnacle Health Cardiovascular Institute. Dr. Maini has extensive experience in developing structural heart programs.
FoundCare, Inc. is announcing the hiring of Serge Thys, Jr., M.D. Dr. Thys joins the FoundCare health center as a full-time family practice physician.
Dr. Thys recently completed his family medicine residency at the University of Arkansas for Medical Sciences, in Fayetteville, AR. He received his Doctor of Medicine from Ross University School of Medicine in Portsmouth, Dominica and his Bachelor of Science Degree in Biology from Florida Atlantic University.
Baptist Health Medical Group has been honored by the Medical Group Management Association with the Fred Graham Award for Innovation in Improving Community Health, the highest recognition given to a medical group practice for developing creative community health care solutions.
The award recognized the medical group for its innovative approaches to patient care, including the primary care medical home, patient portal, improved communication lines between patients and families and their care team, telehealth, electronic medical records and free health screenings.
“This award reflects the effort of our entire team to fulfill our mission of providing the community with the highest quality care. As a medical group, we are leading the way in delivering programs that enhance the patient experience,” said Bernie Fernandez Jr., M.D., CEO of Baptist Health Medical Group. “Our efforts at transforming how we care for our patients — from providing primary care services conveniently under one roof to improving access to medical services ― are having a lasting impact on our community.”
Dr. H. Thomas Temple recently performed the first Proximal Femoral replacement with an advanced silver coating in the Eastern United States. The patient who is benefiting from this cutting edge procedure is a 55 year old female. The complex procedure involved replacing the patient’s femoral (thigh) bone, and followed two previous procedures in 2014 to eradicate the bone tumor and infection.
According to Dr. Temple, cases of bone cancer requiring bone removal or severe bone loss for other reasons can result in infections, leaving the patient with temporary or permanent life‐altering damage. Dr. Temple used the Intelligent Silver coated MUTARS® prosthesis to replace the patient’s missing bone. This implantable device is coated with a layer of silver which combats infection by reacting when bacteria contact it. The FDA evaluates and approves each patient that may be a candidate for the
Intelligent Silver MUTARS prosthesis, as it is a new and unique technology for the United States.
Dr. Temple is a world‐renowned orthopedic oncologist practicing at the newly established Center for Orthopedic Innovations and was recently appointed Sr. Vice President of Translational Research and Economic Development at Nova Southeastern University. He received intense training in musculoskeletal disaster cases at Walter Reed Medical Center and the prestigious Massachusetts
Orthopaedic surgeon and sports medicine specialist Dr. Jonathan Hersch is the first in Florida to provide the Rotation Medical Rotator Cuff System, a new bioinductive implant that induces formation of tendon-like tissue to treat patients suffering from rotator cuff disease. The minimally invasive system is designed for use during arthroscopic procedures, providing a new option for millions of people suffering from rotator cuff tendon tears in the shoulder joint. Dr. Hersch has an office in Boca Raton with Tenet Florida Physician Services (TFPS), and is on staff at West Boca Medical Center.
“There has been a strong clinical need for a new solution to treat rotator cuff disease. Up until now, rotator cuff repair procedures did not improve the underlying tendon tissue structure and a large number of repaired tendons deteriorated over time and became prone to re-tears,” said Dr. Hersch. “With the Rotation Medical technology we are able to induce new tissue growth, and potentially prevent the progression of rotator cuff disease. This supports my goal to help improve patient quality of life. The ability to intervene earlier may help many patients avoid a lengthy rehabilitation and return to their routines sooner.”
Miami Children’s Health System (MCHS) has joined the University of Florida (UF), University of Miami and Florida State University as well as health care systems, health plans, providers and patients to support patient-centered healthcare research throughout Florida and the nation. The statewide partnership, called the OneFlorida Clinical Research Consortium, is one of the 13 research collaboratives throughout the U.S. to have joined the National Patient-Centered Clinical Research Network, also known as PCORnet. The Florida network was approved for a three-year, $7.9 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to support this research initiative.
PCORnet links researchers, patient communities, clinicians and health systems in research partnerships that involve large volumes of health data. The partnership will enable researchers nationwide to conduct clinical research more quickly and less expensively than is now possible and will ensure that research focuses on the outcomes that matter most to patients and their caregivers. These 13 clinical data research networks, which includes the Miami Children’s Research Institute on the Nicklaus Children’s Hospital campus as part of OneFlorida, are working together to accelerate the translation of promising research findings to improve patient care.
Holy Cross Hospital is now offering 3D mammography (breast tomosynthesis) for breast cancer, which produces a three-dimensional view of breast tissue that helps radiologists identify and characterize individual breast structures without the confusion of overlapping tissue.
According to the Centers for Disease Control and Prevention, not counting some kinds of skin cancer, breast cancer in the United States is the most common cancer in women, regardless of race or ethnicity. It is the most common cause of death from cancer among Hispanic women and the second most common cause of death from cancer among white, black, Asian/Pacific Islander, and American Indian/Alaska Native women.
The Dorothy Mangurian Comprehensive Women’s Center at Holy Cross HealthPlex utilizes the Selenia® Dimensions® breast tomosynthesis system made by Hologic, a world leader in digital mammography. Studies have demonstrated breast cancer screening with tomosynthesis when combined with a conventional 2D mammography has a 40 percent higher invasive cancer detection rate than conventional 2D mammography alone.
“We believe breast tomosynthesis will benefit all patients undergoing screenings and diagnostic mammographies, while offering the greatest benefit to women with dense breasts,” said Howard Rubinson, MD, Diagnostic Radiologist.
The tomosynthesis screening experience is similar to a traditional mammogram. During a tomosynthesis exam, multiple, low-dose images of the breast are acquired at different angles. These images are then used to produce a series of one-millimeter thick slices that can be viewed as a 3D reconstruction of the breast.
According to studies, the tomosynthesis technology gives radiologists increased confidence resulting in an up to 40 percent reduction in recall rates for further testing.
Susan G. Komen, the world’s largest nonprofit funder of breast cancer research, announced new grants to 124 researchers in 25 states and 8 countries, with about half of the grants targeted to early-career researchers squeezed by stagnation in federal research dollars.
The grants include $630,000 in new funding for research at two institutions in Florida, bringing Komen’s total research investment in Florida to $12,630,000 since 1982.
The 2015 research grants expand Komen’s ongoing commitment to funding early-career scientists, that is, recent graduates and those trying to establish independent research careers. This group has been especially hard hit by real-dollar declines of as much as 25 percent in federal research funding over the past decade.
“We committed two years ago to do all that we can to ensure that talented early-career investigators remain in the breast cancer research field, while continuing our support for established researchers,” said Komen President and CEO Judith A. Salerno, M.D., M.S. “We cannot afford to lose talented scientists to other fields for lack of funding.”
This year’s research slate brings Komen’s total research investment to more than $889 million since 1982, the largest of any nonprofit, and second only to the U.S. government.
During the Nova Southeastern University (NSU) Health Professions Division Commencement Ceremony, Elaine M. Wallace, D.O., M.S., M.S., M.S., NSU College of Osteopathic Medicine dean, received the Morton Terry Founders’ Award, which honors inspirational leadership in education and health care administration.
“Your commitment to the community—including our university and the many organizations you have served—is a tribute to the high standards that govern your life,” said George L. Hanbury II, Ph.D., NSU president and chief executive officer. “Throughout your career, both personally and professionally, you are looked upon by your colleagues and friends as a person of high integrity who is driven by impeccable principles and ethics.”